Physician profile

Lance E Oxford

Otolaryngology/Facial Plastic Surgery · Dallas, TX

NPI 1912950874

$312.00

in general payments reported to CMS, 2019-2025

7 companies · $208 in 2025

The $208 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$277.83

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $117.22 2025 Keytruda
Ethicon US, LLC $87.17 2023-2025 Harmonic, Vistaseal
Medtronic, INC. $32.17 2023 Pteye Parathyroid Detection System
Inspire Medical Systems, INC. $27.63 2025 Inspire
Stryker Corporation $17.99 2020
Access Pro Medical, LLC $16.18 2022
Acera Surgical, INC. $13.64 2025 Restrata Wound Matrix

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lance E Oxford

$312.00

in general payments reported 2019-2025

Years
2020-2025
Top company
Merck Sharp & Dohme LLC
Context
The $208 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).

https://glasscript.com/doctor/313372/lance-e-oxford

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.